AbbVie Inc. stock price

AbbVie Inc. latest news:


  • 12/22/2017 15:51:23

    UPDATE 3-U.S. judge tosses verdict against AbbVie in AndroGel case

    Dec 22 (Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel.

  • 12/22/2017 14:02:41

    U.S. judge tosses verdict against AbbVie in AndroGel case

    A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc (ABBV) that was first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel.

  • 10/27/2017 10:33:34

    BRIEF-AbbVie, on conf call, says we need to see HCV market sort itself out

    * AbbVie CEO, on conf call, says we need to see HCV market sort itself out

  • 10/27/2017 08:55:25

    Why AbbVie Won Big in Q3, and Can Keep Winning


  • 10/27/2017 05:41:21

    AbbVie increases cash dividend by 11% ahead of earnings

    Ahead of its third-quarter earnings release on Friday, AbbVie Inc. said the board will increase the company's cash dividend by 11% to 71 cents a share from 64 cents. The dividend will be paid out Feb. 15, 2018 to shareholders of record as of Jan. 12, 2018. Since its inception in 2013, AbbVie has increased its dividend by more than 77%. Shares of AbbVie are up 43% in the year to date, while the S&P 500 index is up more than 14% and the Dow Jones Industrial Average is up more than 18%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Abercrombie & Fitch CompanyANF | Aberdeen Greater China FundGCH | Aberdeen Japan Equity FundJEQ | Aberdeen Singapore FundSGF | ABM Industries IncorporatedABM | Acadia Realty TrustAKR | Accenture plc.ACN | Acco Brands CorporationACCO | Accuride Corporation NewACW | Ace LimitedACE |